 Home > Active Ingredient News > Endocrine System > JCEM: Efficacy of teriparatide combined with denosumab on spinal volume BMD and stiffness in premenopausal women with idiopathic osteoporosis

JCEM: Efficacy of teriparatide combined with denosumab on spinal volume BMD and stiffness in premenopausal women with idiopathic osteoporosis

 Last Update: 2022-05-13
 Source: Internet
 Author: User

Tags

bulk density calculation

primary sewage treatment

endocrine system diseases

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Premenopausal women with idiopathic osteoporosis have marked deficits in bone density, microarchitecture, and strength

Osteoporosis

Recently, a research article was published in the Journal of Clinical Endocrinology & Metabolism, an authoritative journal in the field of endocrine and metabolic diseases.

The researchers conducted an auxiliary analysis of central quantitative computed tomography scans at baseline, after teriparatide treatment, and after denosumab treatment in a randomized trial

Trabecular vBMD (25%), other vBMD parameters and stiffness (21%) were significantly increased after teriparatide treatment (all p<0.

CONCLUSIONS: Continuous treatment with teriparatide and denosumab resulted in a significant increase in bulk density and stiffness, supporting the use of this regimen in premenopausal women with idiopathic osteoporosis

Significant increases in bulk density and stiffness following continuous treatment with teriparatide and denosumab support the use of this regimen in premenopausal women with idiopathic osteoporosis

Original source:

Sanchita Agarwal, et al.

Spine volumetric BMD and strength in premenopausal idiopathic osteoporosis: Effects of teriparatide followed by

denosumab

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

USP Factory Direct Purity Degree 99% Progesterone

CAS No.: 57-83-0

Pharmacy Grade

$180-230/KG FOB

15-EPI CLOPROSTENOL

CAS No.: 55028-72-3

$1/KG EXW

Acetyl Dipeptide-1 cetyl ester

CAS No.: 196604-48-5

$1/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.